Article
Preclinical Studies of Granulysin-Based Anti-Tn Immunotoxins as A New Antitumoral Treatment
2022-03-01
Abstract excerpt
Two granulysin (GRNLY) based immunotoxins were generated, one containing the scFv of the SM3 mAb (SM3GRNLY) and the other the scFv of the AR20.5 mAb (AR20.5GRNLY). These mAb recognize different amino acid sequences of aberrantly O-glycosilated MUC1, also known as the Tn antigen, expressed in a variety of tumor cell types. We first demonstrated the affinity of these immunotoxins for their antigen using surface plas...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 817c5f2e-174d-56b3-b4f2-07cf37603ae5
- DOI
- 10.20944/preprints202202.0268.v2
